News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,267 Results
Type
Article (40892)
Company Profile (267)
Press Release (680098)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204696)
Career Advice (2023)
Deals (35532)
Drug Delivery (110)
Drug Development (81381)
Employer Resources (173)
FDA (16403)
Job Trends (14941)
News (346406)
Policy (32725)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2567)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (49602)
ALS (167)
Alzheimer's disease (1658)
Antibody-drug conjugate (ADC) (305)
Approvals (16668)
Artificial intelligence (500)
Autoimmune disease (143)
Automation (37)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (55)
Breast cancer (632)
Cancer (4753)
Cardiovascular disease (395)
Career advice (1708)
Career pathing (36)
CAR-T (275)
CDC (44)
Celiac Disease (2)
Cell therapy (728)
Cervical cancer (36)
Clinical research (69492)
Collaboration (1667)
Company closure (4)
Compensation (1138)
Complete response letters (52)
COVID-19 (2707)
CRISPR (87)
C-suite (810)
Cystic fibrosis (143)
Data (6145)
Decentralized trials (2)
Denatured (25)
Depression (130)
Diabetes (495)
Diagnostics (6676)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (242)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90039)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117210)
Executive appointments (958)
FDA (19476)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1445)
Gene editing (191)
Generative AI (42)
Gene therapy (581)
GLP-1 (962)
Government (4651)
Grass and pollen (6)
Guidances (383)
Healthcare (18872)
HIV (55)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (244)
Immuno-oncology (53)
Indications (103)
Infectious disease (2965)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (242)
Interviews (315)
IPO (16638)
IRA (49)
Job creations (3641)
Job search strategy (1428)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (545)
Leadership (31)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (639)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (776)
MASH (161)
Medical device (13757)
Medtech (13809)
Mergers & acquisitions (19952)
Metabolic disorders (1250)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (307)
Neuropsychiatric disorders (86)
Neuroscience (2865)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4511)
Now hiring (65)
Obesity (586)
Opinion (258)
Ovarian cancer (164)
Pain (195)
Pancreatic cancer (222)
Parkinson's disease (279)
Partnered (33)
Patents (486)
Patient recruitment (469)
Peanut (55)
People (58815)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21667)
Phase 2 (30584)
Phase 3 (22790)
Pipeline (5073)
Policy (278)
Postmarket research (2564)
Preclinical (9193)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (814)
Real estate (5955)
Recruiting (69)
Regulatory (24416)
Reports (51)
Research institute (2384)
Resumes & cover letters (351)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (237)
Series B (184)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3612)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (53)
Vaccines (983)
Venture capital (86)
Weight loss (376)
Women's health (87)
Worklife (18)
Date
Today (14)
Last 7 days (592)
Last 30 days (2212)
Last 365 days (29796)
2026 (2812)
2025 (30186)
2024 (35224)
2023 (40082)
2022 (51181)
2021 (55718)
2020 (54100)
2019 (46556)
2018 (35031)
2017 (32121)
2016 (31488)
2015 (37559)
2014 (31321)
2013 (26352)
2012 (28576)
2011 (29270)
2010 (27335)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39211)
Australia (6426)
California (11158)
Canada (3249)
China (1083)
Colorado (471)
Connecticut (469)
Delaware (332)
Europe (84451)
Florida (1660)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (850)
India (62)
Indiana (513)
Iowa (22)
Japan (417)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1370)
Massachusetts (7985)
Michigan (319)
Minnesota (622)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2966)
New Mexico (28)
New York (2939)
North Carolina (1434)
North Dakota (8)
Northern California (5435)
Ohio (329)
Oklahoma (21)
Oregon (41)
Pennsylvania (2253)
Puerto Rico (22)
Rhode Island (47)
South America (1107)
South Carolina (65)
South Dakota (1)
Southern California (4344)
Tennessee (172)
Texas (1718)
United States (39538)
Utah (333)
Vermont (1)
Virginia (256)
Washington D.C. (81)
Washington State (913)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
721,267 Results for "tekni plex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research
January 13, 2026
·
2 min read
Press Releases
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission
December 4, 2025
·
5 min read
Press Releases
PolyPid’s D-PLEX₁₀₀ Wins BioTech Breakthrough Award for “Therapeutics Solution of the Year”
November 7, 2025
·
6 min read
Deals
Tekni-Plex Acquires Johnson Plastic Group, Expands Medical Device Footprint
Tekni-Plex Healthcare has acquired precision extrusion manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand the company’s patient care solutions platform.
October 7, 2021
·
2 min read
Business
Brenda Chamulak named as President, Tekni-Plex Packaging Products
Brenda Chamulak has joined Tekni-Plex as president of its newly created Packaging Products division.
October 8, 2020
·
1 min read
Press Releases
Plex Research Partners With Ginkgo Bioworks on Artificial Intelligence (AI)-Powered Drug Discovery to Identify Novel Disease Mechanisms and Pathways
April 3, 2025
·
3 min read
Press Releases
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX₁₀₀ Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary Endpoints
June 9, 2025
·
9 min read
Drug Development
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform
PolyPid Ltd. today announced the publication of positive preclinical results demonstrating, for the first time, the safety profile of D-PLEX.
October 4, 2023
·
4 min read
Drug Development
PolyPid to Host Virtual KOL Event on June 17, 2024, and Provide an Update on the Company’s Ongoing D-PLEX₁₀₀ Phase 3 Trial
PolyPid Ltd. announced that it will host a virtual Key Opinion Leader event on Monday, June 17, 2024, at 10:00 AM ET, to discuss the significant unmet medical need in surgical site infections and provide an update on the Company’s ongoing D-PLEX100 Phase 3 trial.
June 10, 2024
·
5 min read
Drug Development
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that it has enrolled the 200th patient in its ongoing SHIELD II Phase 3 trial for D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery with large incisions.
April 30, 2024
·
6 min read
1 of 72,127
Next
